ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1299

PTEN Controls Osteoclastogenesis and Inflammatory Bone Destruction In a TNF-Driven Model Of Arthritis

Stephan Blueml1, Gernot Schabbauer2, Antonia Puchner3, Victoria Saferding4, Emine Sahin2, Julia Brunner5, Tobias Lohmeyer5, Josef S. Smolen6 and Kurt Redlich7, 1Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Vascular Biology and Thrombosis research, Medical University Vienna, Vienna, Austria, 3Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 4Rheumatology, Medical University of Vienna, Vienna, Austria, 5Medical University Vienna, Vienna, Austria, 6Medical University of Vienna, Vienna, Austria, 7Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models and osteoclastogenesis

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Local bone destruction in inflammatory arthritides in humans such as rheumatoid arthritis is a serious health burden and the major cause of disability and severely reduced quality of life in these diseases. Damage to the bony structures is exclusively mediated by a special cell type, the osteoclast (OC). Therefore, it is important to understand factors and pathways regulating the generation of OCs under inflammatory conditions. In this study, we analyzed the impact of the PI3-Kinase/PTEN axis on OC generation and bone biology in an animal model of inflammatory bone loss. 

Methods:

We induced osteoclastogenesis in wt and PTEN deficient bone marrow cells and measured the generation of OCs, their resorptive capacity and induction of OC differentiation markers in vitro.  Moreover, we analyzed mice with a monocyte/macrophage-specific deletion of PTEN (myeloid specific PTEN-/-) by bone histomorphometry and crossed these mice into hTNFtg animals. 

Results:

We show that myeloid specific PTEN-/- mice display increased osteoclastogenesis in vitro and in vivo compared to wt mice. Loss of PTEN did not affect the generation or survival of osteoclast precursor cells. However, PTEN deficiency greatly enhanced RANKL-induced expression of the master transcription factor of osteoclastogenesis, NFATc1, resulting in markedly increased terminal differentiation of osteoclasts in vitro. Under non-inflammatory conditions, enhanced osteoclastogenesis did not result in systemic bone loss in vivo. However, when we crossed myeloid specific PTEN-/- into hTNFtg mice we found significantly decreased grip strength scores in myeloid specific PTEN-/-/hTNFtg mice compared to wt hTNFtg mice. Joint swelling scores, however, were not different between both groups. In line, myeloid specific PTEN-/-/hTNFtg mice displayed enhanced local bone destruction as well as OC formation in the inflamed joints, whereas the extent of synovial inflammation was not different between the groups. Analysis of the synovial membranes of wt and myeloid specific PTEN-/- animals revealed similar relative compositions of the cellular infiltrate including neutrophil granulocytes as well as macrophages which can serve as OC precursors. This suggests that increased capacity for osteoclastogenic differentiation rather than enhanced recruitment of precursor cells is responsible for the enhanced local generation of OCs. 

Conclusion:

Taken together, these data demonstrate that sustained PI3-Kinase activity in myeloid cells specifically elevated the osteoclastogenic potential of these cells, leading to enhanced inflammatory local bone destruction. Therefore, targeting the PI3-Kinase pathway therapeutically may be especially useful for the prevention of structural joint damage.


Disclosure:

S. Blueml,
None;

G. Schabbauer,
None;

A. Puchner,
None;

V. Saferding,
None;

E. Sahin,
None;

J. Brunner,
None;

T. Lohmeyer,
None;

J. S. Smolen,
None;

K. Redlich,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pten-controls-osteoclastogenesis-and-inflammatory-bone-destruction-in-a-tnf-driven-model-of-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology